Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Name: Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
Published: 2021
License: Public Domain

AbbVie · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

gene-therapy

neovascular age-related macular degeneration (namd), gene therapy, amd, wet amd, wamd, namd, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Related documents